Susquehanna International Group, LLP Fortress Biotech, Inc. Call Options Transaction History

Susquehanna International Group, LLP

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2023 Nov 14, 2023	BUY	$0.28 - $0.65 $9,576 - $22,230	34,200 Added 66.28%	85,800 $24,000
Q2 2023 Aug 11, 2023	BUY	$0.49 - $0.82 $25,284 - $42,312	51,600 New	51,600 $28,000
Q2 2022 Aug 15, 2022	SELL	$0.8 - $1.5 $6,000 - $11,250	-7,500 Reduced 6.55%	107,000 $90,000
Q1 2022 May 16, 2022	SELL	$1.24 - $2.75 $34,844 - $77,275	-28,100 Reduced 19.71%	114,500 $156,000
Q4 2021 Feb 14, 2022	SELL	$2.42 - $3.65 $41,624 - $62,780	-17,200 Reduced 10.76%	142,600 $357,000
Q3 2021 Nov 15, 2021	BUY	$2.82 - $3.7 $160,740 - $210,900	57,000 Added 55.45%	159,800 $515,000
Q2 2021 Aug 11, 2021	BUY	$3.5 - $5.48 $296,450 - $464,156	84,700 Added 467.96%	102,800 $367,000
Q1 2018 May 15, 2018	SELL	$3.42 - $5.35 $15,048 - $23,540	-4,400 Reduced 19.56%	18,100 $82,000
Q3 2017 Nov 14, 2017	BUY	$3.83 - $4.89 $86,175 - $110,025	22,500	22,500 $99,000

862K

Ticker FBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,735,000
Market Cap $185M
Description
Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch sympt...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.